查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1667943

腎臟醫療器材和服務市場 - 全球產業規模、佔有率、趨勢、機會與預測，按產品、應用、地區和競爭細分，2020-2030 年預測

Renal Medical Devices and Services Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, Application, By Region, & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球腎臟醫療設備和服務市場價值為 159 億美元，預計在整個預測期內將穩步成長，到 2030 年的年複合成長率(CAGR) 為 5.15%。這些設備在腎臟病學（腎臟的研究）中至關重要，並用於各種醫療保健環境，包括醫院、診所和家庭護理。該市場涵蓋了廣泛的技術，包括超音波機器、CT 掃描儀和 MRI 機器等影像設備，用於診斷腫瘤、囊腫和腎結石等腎臟相關疾病。慢性腎病 (CKD) 和末期腎臟病 (ESRD) 等腎臟疾病盛行率的上升是推動市場成長的主要因素。促成因素包括人口老化、糖尿病、高血壓以及與生活方式相關的健康問題，這些因素擴大了需要腎臟醫療設備和服務的患者群體。

市場概況
預測期 2026-2030
2024 年市場規模 159億美元
2030 年市場規模 215.4 億美元
2025-2030 年複合年成長率 5.15％
成長最快的領域 透析設備
最大的市場 北美洲

*關鍵市場促進因素**

*慢性腎病 (CKD) 和末期腎病 (ESRD) 盛行率不斷上升**

CKD 和 ESRD 發生率的不斷上升是全球腎臟醫療設備和服務市場擴張的主要驅動力。隨著全球腎臟疾病發病率的上升，對治療、設備和服務的需求持續成長。全球約有 7 億人患有 CKD，如果考慮到急性腎損傷 (AKI) 和腎衰竭的額外負擔，這一數字將上升至約 8.5 億，影響到世界人口的 10% 以上。由於缺乏廣泛的早期檢測和篩檢計劃，這一數字可能被低估。 CKD 發展為 ESRD 需要持續的醫療干預，主要是透析和相關治療。隨著越來越多的患者患上 ESRD，對透析機、腎臟監測器、過濾系統和其他必需腎臟設備的需求也隨之增加，從而推動市場成長。此外，糖尿病、高血壓和肥胖等危險因子的盛行率不斷上升，進一步增加了全球腎臟疾病的負擔，凸顯了對有效管理策略的迫切需求。糖尿病是腎臟疾病的主要原因，而高血壓和糖尿病合計佔新發腎衰竭病例的三分之二。

*主要的市場挑戰**

*經濟不確定性**

經濟不穩定會影響市場的各個方面，包括購買決策、醫療保健預算以及對醫療設備和服務的投資。在經濟不確定時期，醫院和診所等醫療機構可能會面臨預算限制，導致資本支出受到限制。因此，對腎臟醫療設備和服務的投資可能會被延遲。由於醫療保健機構尋求更具成本效益的解決方案，經濟挑戰也會對醫療器材製造商和服務提供者施加價格壓力，這可能會影響利潤率。此外，經濟不確定性可能會減少研發計畫的資金，從而阻礙腎臟醫療設備的創新。市場的波動，特別是股票價格和投資者信心的波動，也可能受到經濟狀況的影響，患者的行為也可能受到影響，有些人選擇推遲選擇性手術或探索成本較低的替代方案。

*主要市場趨勢**

*居家血液透析**

居家血液透析越來越受歡迎，它使患有 ESRD 的患者能夠在自己舒適的家中接受透析治療。許多患者更喜歡這種選擇，因為它提供了更大的靈活性，可以適應他們的個人日程安排。這種以患者為中心的方法刺激了對居家血液透析設備和服務的需求。接受居家透析的患者由於能夠更頻繁地或更長時間來進行透析，因此可以獲得更好的臨床結果。此外，居家血液透析消除了頻繁前往醫療機構的需要，減輕了患者及其家人的負擔。它還可以降低醫療環境中常見的感染風險。從成本角度來看，家庭血液透析透過減少與機構照護相關的費用，提供了更實惠的替代方案。製造商正在開發更方便用戶使用且緊湊的機器，以方便家庭治療，而遠距醫療和遠端監控技術使醫療保健提供者能夠管理患者的進展並根據需要調整治療，從而提高安全性和有效性。

*主要市場參與者**

雅培實驗室公司

B Braun Melsungen AG

百特國際公司

碧迪公司

波士頓科學公司

DaVita 醫療保健合作夥伴公司

費森尤斯集團

資訊諮詢公司

美敦力公司

尼普洛公司

*市場區隔**

全球腎臟醫療設備與服務市場細分如下：

**按產品：**

透析設備

腎臟去神經支配裝置

穿戴式人工腎臟裝置

遠端栓塞保護裝置

**按應用：**

腎衰竭

慢性腎臟病 (CKD)

末期腎病 (ESRD)

腎結石疾病

高血壓

糖尿病

其他

**按地區：**

北美（美國、加拿大、墨西哥）

亞太地區（中國、印度、韓國、澳洲、日本）

歐洲（德國、法國、英國、西班牙、義大利）

南美洲（巴西、阿根廷、哥倫比亞）

中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國）

*競爭格局**

市場競爭格局包括對全球腎臟醫療設備和服務市場主要公司的詳細分析。

*可自訂**

該報告可以根據公司的具體需求進行客製化。 TechSci Research 提供客製化服務，例如納入其他市場參與者（最多五家）的詳細公司簡介。

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：腎臟醫療設備與服務市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（透析設備、腎臟去神經支配裝置、穿戴式人工腎臟裝置、遠端栓塞保護裝置）
    • 應用（腎衰竭、慢性腎臟病、末期腎病、腎結石疾病、高血壓、糖尿病、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第 6 章：北美腎臟醫療設備與服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第7章：歐洲腎臟醫療設備與服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太腎臟醫療設備與服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲腎臟醫療設備與服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲腎臟醫療設備和服務市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 13 章：全球腎臟醫療設備與服務市場：SWOT 分析

第 14 章：波特五力分析

第 15 章：競爭格局

  • Abbott Laboratories Inc.
  • B Braun Melsungen AG
  • Baxter International Inc
  • Becton, Dickinson, and Company
  • Boston Scientific Corporation
  • DaVita Healthcare Partners, Inc
  • Fresenius SE & Co. KGaA
  • Infomed SA
  • Medtronic Inc.
  • Nipro Corporation

第 16 章：策略建議

第17章 關於出版商,免責事項

簡介目錄
Product Code: 17685

The Global Renal Medical Devices and Services Market was valued at USD 15.90 billion in 2024 and is projected to experience steady growth throughout the forecast period, with a compound annual growth rate (CAGR) of 5.15% through 2030. Renal medical devices are specialized instruments, equipment, and tools designed to diagnose, treat, and manage conditions related to the kidneys and the urinary system. These devices are crucial in nephrology (the study of kidneys) and are utilized in various healthcare settings, including hospitals, clinics, and home care. The market encompasses a wide range of technologies, including imaging devices such as ultrasound machines, CT scanners, and MRI machines, which are used to diagnose kidney-related conditions such as tumors, cysts, and kidney stones. The rising prevalence of kidney diseases, such as chronic kidney disease (CKD) and end-stage renal disease (ESRD), is a major factor driving market growth. Contributing factors include aging populations, diabetes, hypertension, and lifestyle-related health issues, which are expanding the patient base requiring renal medical devices and services.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 15.90 Billion
Market Size 2030USD 21.54 Billion
CAGR 2025-20305.15%
Fastest Growing SegmentDialysis Equipment
Largest MarketNorth America

*Key Market Drivers**

*Increasing Prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)**

The growing incidence of CKD and ESRD is a key driver of expansion in the Global Renal Medical Devices and Services Market. As kidney disease rates rise globally, the demand for treatments, devices, and services continues to grow. Approximately 700 million people globally are affected by CKD, and when considering the additional burden of Acute Kidney Injury (AKI) and kidney failure, the number rises to about 850 million, impacting over 10% of the world's population. This figure is likely an underrepresentation due to the lack of widespread early detection and screening programs. The progression of CKD to ESRD demands continuous medical interventions, primarily dialysis and related therapies. As more patients develop ESRD, the need for dialysis machines, kidney monitors, filtration systems, and other essential renal devices increases, driving market growth. Additionally, the rising prevalence of risk factors such as diabetes, hypertension, and obesity further contributes to the global burden of renal disease, highlighting the urgent need for effective management strategies. Diabetes, in particular, is the leading cause of kidney disease, while hypertension and diabetes together account for two-thirds of new kidney failure cases.

*Key Market Challenges**

*Economic Uncertainty**

Economic instability can influence various aspects of the market, including purchasing decisions, healthcare budgets, and investments in medical devices and services. During periods of economic uncertainty, healthcare facilities, including hospitals and clinics, may face budget constraints, leading to limitations on capital expenditures. As a result, investments in renal medical devices and services may be delayed. Economic challenges can also exert pricing pressure on medical device manufacturers and service providers, as healthcare organizations seek more cost-effective solutions, potentially affecting profit margins. Additionally, economic uncertainty can reduce funding for research and development initiatives, impeding innovation in renal medical devices. The market's volatility, especially in terms of stock prices and investor confidence, may also be affected by economic conditions, as could patient behavior, with some opting to delay elective procedures or explore lower-cost alternatives.

*Key Market Trends**

*Home Hemodialysis**

Home hemodialysis is becoming increasingly popular, offering patients with ESRD the ability to undergo dialysis treatments in the comfort of their own homes. Many patients prefer this option as it provides greater flexibility and can be adapted to their personal schedules. This patient-centered approach has spurred demand for home hemodialysis devices and services. Patients undergoing home dialysis can experience better clinical outcomes due to the ability to dialyze more frequently or for longer durations. Furthermore, home hemodialysis eliminates the need for frequent travel to healthcare facilities, reducing the burden on patients and their families. It can also decrease the risk of exposure to infections commonly found in healthcare settings. From a cost perspective, home hemodialysis offers a more affordable alternative by reducing the expenses associated with facility-based care. Manufacturers are developing more user-friendly and compact machines to facilitate home treatments, while telehealth and remote monitoring technologies enable healthcare providers to manage patients' progress and adjust treatments as needed, enhancing both safety and effectiveness.

*Key Market Players**

Abbott Laboratories Inc.

B Braun Melsungen AG

Baxter International Inc.

Becton, Dickinson, and Company

Boston Scientific Corporation

DaVita Healthcare Partners, Inc.

Fresenius SE & Co. KGaA

Infomed SA

Medtronic Inc.

Nipro Corporation

*Market Segmentation**

The Global Renal Medical Devices and Services Market is segmented as follows:

**By Product:**

Dialysis Equipment

Renal Denervation Devices

Wearable Artificial Kidney Device

Distal Embolic Protection Devices

**By Application:**

Kidney Failure

Chronic Kidney Disease (CKD)

End-Stage Kidney Disease (ESRD)

Renal Kidney Stone Disease

Hypertension

Diabetes

Others

**By Region:**

North America (United States, Canada, Mexico)

Asia-Pacific (China, India, South Korea, Australia, Japan)

Europe (Germany, France, United Kingdom, Spain, Italy)

South America (Brazil, Argentina, Colombia)

Middle East & Africa (South Africa, Saudi Arabia, UAE)

*Competitive Landscape**

The competitive landscape of the market includes a detailed analysis of major companies operating in the Global Renal Medical Devices and Services Market.

*Customizations Available**

This report can be customized according to the specific needs of a company. TechSci Research offers customizations such as the inclusion of detailed company profiles of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Renal Medical Devices and Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Dialysis Equipment, Renal Denervation Devices, Wearable Artificial Kidney Device, Distal Embolic Protection Devices)
    • 5.2.2. Application (Kidney Failure, Chronic Kidney Disease, End-Stage Kidney Disease, Renal Kidney Stone Disease, Hypertension, Diabetes, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Renal Medical Devices and Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Renal Medical Devices and Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Renal Medical Devices and Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Renal Medical Devices and Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Renal Medical Devices and Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Renal Medical Devices and Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Renal Medical Devices and Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Renal Medical Devices and Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. France Renal Medical Devices and Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Renal Medical Devices and Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia-Pacific Renal Medical Devices and Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Renal Medical Devices and Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Renal Medical Devices and Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Renal Medical Devices and Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Renal Medical Devices and Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Renal Medical Devices and Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. South America Renal Medical Devices and Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Renal Medical Devices and Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Renal Medical Devices and Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Renal Medical Devices and Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. Middle East and Africa Renal Medical Devices and Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Renal Medical Devices and Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Renal Medical Devices and Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Renal Medical Devices and Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Renal Medical Devices and Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

  • 15.1. Abbott Laboratories Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Product & Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Financials (If Listed)
    • 15.1.5. Key Personnel
    • 15.1.6. SWOT Analysis
  • 15.2. B Braun Melsungen AG
  • 15.3. Baxter International Inc
  • 15.4. Becton, Dickinson, and Company
  • 15.5. Boston Scientific Corporation
  • 15.6. DaVita Healthcare Partners, Inc
  • 15.7. Fresenius SE & Co. KGaA
  • 15.8. Infomed SA
  • 15.9. Medtronic Inc.
  • 15.10.Nipro Corporation

16. Strategic Recommendations

17. About Us & Disclaimer